Application

TIGVANZA

BeiGene Switzerland GmbH

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97859267
Filing Date: 03/27/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97859267
MARK INFORMATION
*MARK TIGVANZA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TIGVANZA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK BeiGene Switzerland GmbH
*MAILING ADDRESS Aeschengraben 27
*CITY Basel
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
4051
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Kristen S. Ruisi
ATTORNEY DOCKET NUMBER 140679577478
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME VENABLE, LLP
STREET 151 West 42nd Street, 49th Fl.
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
PHONE 212-503-0559
FAX 212-307-5598
EMAIL ADDRESS KSRuisi@venable.com
CORRESPONDENCE INFORMATION
NAME Kristen S. Ruisi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE KSRuisi@venable.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NYIPDocketing@venable.com; khamilton@venable.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /KR/
SIGNATORY'S NAME Kristen S. Ruisi
SIGNATORY'S POSITION Attorney of Record, NY Bar Member
SIGNATORY'S PHONE NUMBER 212-503-0559
DATE SIGNED 03/27/2023
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97859267
Filing Date: 03/27/2023

To the Commissioner for Trademarks:

MARK: TIGVANZA (Standard Characters, see mark)
The literal element of the mark consists of TIGVANZA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, BeiGene Switzerland GmbH, a corporation of Switzerland, having an address of
      Aeschengraben 27
      Basel 4051
      Switzerland
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Kristen S. Ruisi. Kristen S. Ruisi of VENABLE, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      151 West 42nd Street, 49th Fl.
      New York, New York 10036
      United States
      212-503-0559(phone)
      212-307-5598(fax)
      KSRuisi@venable.com
The docket/reference number is 140679577478.
Kristen S. Ruisi submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Kristen S. Ruisi
       PRIMARY EMAIL FOR CORRESPONDENCE: KSRuisi@venable.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NYIPDocketing@venable.com; khamilton@venable.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /KR/   Date: 03/27/2023
Signatory's Name: Kristen S. Ruisi
Signatory's Position: Attorney of Record, NY Bar Member
Signatory's Phone Number: 212-503-0559
Signature method: Sent to third party for signature
Payment Sale Number: 97859267
Payment Accounting Date: 03/27/2023

Serial Number: 97859267
Internet Transmission Date: Mon Mar 27 17:40:38 ET 2023
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202303271740392
92913-97859267-86080a7262bc855beeaa93195
a43bd2c8287553813328fa4a753ebf836793ef87
3d-CC-40388820-20230327155834745108

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed